News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Seattle Genetics has been upgraded to ‘outperform’ by an analyst based on its antibody-drug conjugate (ADC) technology platforms, pipeline and the potential of Adcetris to become a blockbuster.
Biotech Advaxis has selected CMO SynCo Bio Partners B.V to manufacture Advaxis' potential cervical cancer immunotherapy.
GE Healthcare has received patent approval for a system which prevents illegal manufacturing and unauthorized operation of disposable bioprocess components.
Pfizer and MIT have announced a new three-year collaboration to advance biopharmaceutical discovery using synthetic biology.